
Vima Therapeutics
Developer of oral therapeutics designed for the treatment of movement disorders. The company offers clinical-stage biotechnology research focused on targeting the underlying causes of dystonia through...
Valuation
$78M
Latest known
Share Price
N/A
Total Raised
$60M
Last Round
N/A